Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan 160 mg in Chinese Hypertension Patients
NCT01541189Phase 4Completed
- Sponsor
- Novartis
- Start
- Feb 2012
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in hypertension (HTN), sponsored by Novartis. Started Feb 2012; status: completed.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01541189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541189.